Search results
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 5 days ago...20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients with moderately to severely active ulcerative colitisa (UC) receiving subcutaneous (SC) TREMFYA® (guselkumab) 200 mg...
1 in 7 Gen Z credit card users are ‘maxed out’ — here are 3 ways to get out of debt
The Times of Northwest Indiana· 5 days agoThere’s never a good time to carry a credit card balance, but right now is arguably the worst time....
1 in 7 Gen Z credit card users are ‘maxed out’ — here are 3 ways to get out of debt
Quad-City Times· 5 days agoAriel Barnes plunged into a credit card debt spiral in college, and a decade later she’s yet to...